Learn how clinical operations leaders can build technology adoption, transform workflows, and cultivate digitally savvy ...
Gilead's ARTISTRY-2 trial shows BIC/LEN is non-inferior to Biktarvy in virologically suppressed adults with HIV, with no new safety signals. ARTISTRY-2's design involved a randomized, double-blind ...
In today’s ACT Brief, we look at new evidence showing how targeted training can build research readiness at community cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback